Grantham, Mayo, Van Otterloo & Co (GMO)’s Matsons MATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$956K Buy
5,831
+695
+14% +$108K ﹤0.01% 510
2025
Q4
$635K Buy
5,136
+332
+7% +$35.7K ﹤0.01% 560
2025
Q3
$474K Sell
4,804
-1,594
-25% -$170K ﹤0.01% 531
2025
Q2
$712K Hold
6,398
﹤0.01% 507
2025
Q1
$820K Sell
6,398
-3,586
-36% -$492K ﹤0.01% 473
2024
Q4
$1.35M Sell
9,984
-488
-5% -$71.1K ﹤0.01% 401
2024
Q3
$1.49M Buy
10,472
+3,780
+56% +$497K ﹤0.01% 394
2024
Q2
$876K Buy
6,692
+1,346
+25% +$156K ﹤0.01% 407
2024
Q1
$601K Sell
5,346
-770
-13% -$86.7K ﹤0.01% 426
2023
Q4
$670K Sell
6,116
-152
-2% -$14.4K ﹤0.01% 392
2023
Q3
$556K Hold
6,268
﹤0.01% 485
2023
Q2
$487K Sell
6,268
-3,200
-34% -$219K ﹤0.01% 562
2023
Q1
$565K Sell
9,468
-1,000
-10% -$64.4K ﹤0.01% 550
2022
Q4
$654K Buy
+10,468
New +$692K ﹤0.01% 553
2021
Q4
Sell
-7,000
Closed -$565K 710
2021
Q3
$565K Buy
+7,000
New +$518K ﹤0.01% 585
2019
Q2
Sell
-17,400
Closed -$628K 744
2019
Q1
$628K Buy
+17,400
New +$601K ﹤0.01% 554
2017
Q1
Sell
-6,219
Closed -$220K 617
2016
Q4
$220K Sell
6,219
-6,665
-52% -$257K ﹤0.01% 467
2016
Q3
$514K Sell
12,884
-118,691
-90% -$4.4M ﹤0.01% 393
2016
Q2
$4.25M Buy
131,575
+80,375
+157% +$2.78M 0.02% 310
2016
Q1
$2.06M Buy
+51,200
New +$2.01M 0.01% 367

Other funds holding MATX

Grantham, Mayo, Van Otterloo & Co (GMO)'s MATX Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Matsons (MATX) stake by 14% in Q1 2026, buying an estimated $108K and bringing the position to 5,831 shares worth $956K. The position accounts for ﹤0.01% of the portfolio, ranked #510.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in MATX in Q1 2016 and has held it in 20 quarters since. The position peaked at $4.25M in Q2 2016. 394 funds tracked by Wall St. Rank hold MATX as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 5,831 shares of Matsons worth $956K as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 695 Matsons shares in Q1 2026, an estimated $108K.
  • Matsons made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #510 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Matsons in Q1 2016 and has held it in 20 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Matsons position peaked at $4.25M in Q2 2016.
  • 394 funds tracked by Wall St. Rank held Matsons as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.